CAS: 31362-50-2; Bombesin
- 英文名称Bombesin
- 中文名称蛙皮素
- IUPAC名称(S)-N1-((5S,8S,11S,17S,20S,23S,26S,29S,35S,38S)-11-((1H-imidazol-5-yl)methyl)-23-((1H-indol-3-yl)methyl)-43-amino-29-(2-amino-2-oxoethyl)-26-(3-amino-3-oxopropyl)-5-carbamoyl-43-imino-8,35-diisobutyl-17-isopropyl-20-methyl-7,10,13,16,19,22,25,28,31,34,37-undecaoxo-2-thia-6,9,12,15,18,21,24,27,30,33,36,42-dodecaazatritetracontan-38-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)pentanediamide
- 其它别名Bombesin acetate hydrate; 2-L-Glutamine-6-L-asparagine-alytesin
- CAS编号31362-50-2
- MFCD编号:MFCD00167514
- FDA UNII编号:PX9AZU7QPK
- 分子式:C71H110N24O18S分子量:1619.85
- 产品CID: 1302566
- 同类组份化合物CAS31362-50-2 (free base)33910-70-2 (2HCl)
- 产品分类生物化工 → 多肽
物理性质
MSDS等安全信息
- 警示词warning
- 危险描述H303 May be harmful if swallowed+H313 Skin contact may be harmful+H333 Inhalation may be harmful to the body
- 防范说明P264Thoroughly clean after treatmentP280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective maskP305If it enters the eyesP351Rinse carefully with water for a few minutesP338Remove the contact lens(If any)And easy to operate,Continue flushingP337If eye irritation persistsP313Obtain medical advice/care
- 危险品标志F+
- 安全声明22-24/25
- WGK Germany3
上下游产品
N-(fluoren-9-ylmethoxycarbonyl)glycine Fm°C-Val-OH Fm°C-Leu-OH N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine合成工艺路线路线简述
海关参考信息
- 2902200000-苯
2912110000-甲醛
2912120000-乙醛
2921211000-乙二胺 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
参考文献:10.1186/1471-2199-12-29
摘要:Wen X, Chao C, Ives K, Hellmich MR. Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells. BMC Molecular and Cell Biology. 2011 Jul 11;12(1):29. doi: 10.1186/1471-2199-12-29.
参考文献:10.1021/bc2002665
摘要:Ait-Mohand S, Fournier P, Dumulon-Perreault V, Kiefer GE, Jurek P, Ferreira CL, Bénard F, Guérin B. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates. Bioconjug Chem. 2011 Aug 17;22(8):1729–35. doi: 10.1021/bc2002665.
📝 需求与反馈
尽可能描述清楚需求与问题信息
